Serial plasma determinations of the isoenzymes of CPK were performed in all patients (376) admitted to a coronary care unit during a 12-month period with diagnosis of possible acute myocardial infarction. Results were compared with data from other enzyme studies and from the electrocardiogram. An attempt was made to determine the incidence of falsely positive CPK-MB (myocardial-specific form). 'No acute infarction" was diagnosed in all patients in whom neither total CPK nor the isoenzymes of LDH indicated myocardial necrosis, and in whom there were no QRS changes on ECG. Incidence of falsely negative CPK isoenzyme data was also determined. All patients, in whom total CPK was transiently elevated, and LDH, exceeded LDH2, and new QRS changes occurred, were termed "definite" acute infarction. CPK-MB form was present in all 55 of these (0% false negative). Therefore, determination of the isoenzymes of CPK by this method provides both a sensitive and specific indication of acute myocardial infarction.
occur in nearly all patients with acute myocardial infarction, but identical changes may be seen during episodes of ischemia without infarction, and even with noncoronary problems.
Because of the above, most physicians rely heavily on serial changes of enzyme levels in serum to define or exclude the diagnosis of acute myocardial infarction. Alterations of the serum enzymes occur in nearly all cases of proven infarction.3 4However, even the most sensitive of those in routine use, creatine phosphokinase (CPK), can also be elevated by strenuous exercise,5 chronic alcoholism,6 convulsions,7 pulmonary disease,8 cardioversion,9 10 cerebrovascular disease,"1 and intramuscular injections.'2 Thus, while the routine determination of serum CPK is a sensitive index of myocardial necrosis, the enzyme lacks specificity and many false-positive elevations are observed.
In a previous report,13 a method was described for the identification and quantitation in serum or plasma of the CPK-MB isoenzyme of creatine phosphokinase. This hybrid form is known to be in highest concentration in cardiac muscle. The purpose of this study is to describe the value of the CPK-MB isoenzyme in our clinical experience with a large series of patients with suspected acute myocardial infarctioin.
Methods
Sample handling. l3lood samples were withdrawin bv the vacutainer technic, using a tube containing EDTA as anticoagulant. Plasma was immediately separated from the cells by centrifugationi an-d was removed by pipette. Plasma samples were kept cold but niot frozeni uintil enzyme anid isoeuzyme determination-s were mrade within the subsequent 24- Maximum total CPK activity varied from 390 to 3423 IU (upper limit of normal is 130 IU). This peak was attained between 16 and 20 hours after the onset of symptoms. The portion of the total CPK activity attributable to the CPK-MB form varied from 12% to 38%. Thus, the major form of CPK released from myocardial cells is the MM form (muscle band), which is the isoenzyme form normally seen in serum and plasma samples. Also, it is apparent from the temporal relationships of total and CPK-MB that the MM form persists in the plasma for a longer period of time. Thus, the heartspecific isoenzyme is the minor and more transiently observed fraction of CPK released from damaged myocardial cells. 12 groups, and five of these had only one or two patients. Of the remaining groups, 1, 2, and 4 were considered definite infarction; groups 13, 14, and 16 were called definitely no infarction, and group 7 remained unknown. tricular conduction disturbance precluded the appearance of QRS changes or because S-T and Twave changes, but no alteration of the QRS complex, occurred. None of these patients maintained a normal ECG throughout the 5-day monitoring period. No patient had a positive ECG without at least one positive enzyme parameter to confirm the impression of acute infarction (group 12). These observations confirm the generally accepted view that the QRS changes characteristic of myocardial infarction are, indeed, a highly specific index. These data also show, however, that these rigid ECG criteria are absent in a significant number of patients with definite acute myocardial infarction (i.e., 34% in this series). The limited sensitivity of the ECG in the diagnosis of acute infarction emphasizes the importance of identifying enzyme criteria which are equally specific but of greater sensitivity than the ECG.
In recent years, the quantitation of total CPK in serum has become routine in many laboratories, and the method has become useful for identification of acute myocardial infarction. However, because of the high incidence of CPK elevation due to many noncardiac problems, as noted above, it is important to examine the present data with respect to the incidence of falsely elevated levels. A diagnosis of acute myocardial infarction was definitely excluded in 213 of our 328 patients without reference to total CPK (groups 13 and 16). These patients had a history suggesting infarction, but no QRS changes on ECG, no excess of LDH1 over LDH2, and the CPK-MB isoenzyme was absent. Of these 213 patients (group 13), 32 had elevations of total CPK compatible with acute infarction. Thus the incidence of falsely positive total CPK was 15%. However, of the 56 patients with definite myocardial infarction proven by ECG and by characteristic LDH and CPK isoenzyme patterns (groups 1 and 3), 55 (group 1) had a positive total CPK. Thus an elevated total CPK is a highly sensitive index of infarction, but there are significant numbers of patients (15%) in whom an elevated total CPK is misleading.
Total CPK is a sensitive index of infarction, and the CPK-MB forn is found in significant concentration only in heart muscle. The CPK-MB isoenzyme was detected in each of 55 patients with acute myocardial infarction proven by history, ECG, LDH isoenzymes, and total CPK (groups 1 and 5). Of 182 patients in whom the diagnosis of myocardial infarction was excluded by ECG, iso-LDH, Circulation, Volume XLVII, February 1973 and total CPK (groups 15 and 16), only one (0.6%, group 15) had a falsely positive CPK isoenzyme analysis. Thus, when patients are seen within the first 24 hours after the onset of symptoms, the plasma assay for heart band iso-CPK, by the technics noted above, approaches 100% accuracy for either the diagnosis or exclusion of acute myocardial infarction.
In our series of patients with acute myocardial infarction proven by history, ECG, and both total CPK and isoenzyme analysis (groups 1 and 4 One might hypothesize that patients with an "enzyme-proven" acute myocardial infarction, without Q waves on the ECG, would be in a particularly low-risk subgroup. In our series, however, hospital mortality was 22% (14 of 62) when the ECG was diagnostic, and 21% (six of 29) when only S-T and T-wave changes were present. It was not possible to identify any particularly high-or low-risk subgroup of patients on the basis of these diagnostic variables.
Further insight into the specificity of the CPK-MB isoenzyme was obtained by the analysis of plasma enzymes in 50 consecutive patients who underwent coronary angiography using the Judkins technic. Electrocardiograms were obtained daily, before and after the angiogram; none showed definite evidence of acute myocardial infarction. All enzymes (total CPK, MB-CPK, and LDH1: LDH2)
were normal prior to the procedure. Total CPK became elevated in 22 of these patients within 24 hours after the angiography. In one patient the CPK-MB form was detected and was accompanied by LDH1: LDH2 elevation, prolonged pain, and S-T and T-wave changes, confirming the diagnosis of acute infarction. Thus, in 46% of the patients, an elevation of total CPK occurred after coronary angiography. The MB form was present in only one. These observations emphasize the specificity of this isoenzyme and indicate a noncardiac source of the total CPK, probably skeletal muscle at the site of the percutaneous approach.
Discussion
In the mid-1950s Wroblewski, LaDue, and coworkers17-20 established both the experimental evidence and clinical significance of the relationship between acute myocardial infarction and an elevation of enzymes in serum. They noted a correlation between the concentration of these enzymes in serum and the size of myocardial infarction. They also found that transient coronary insufficiency, which produced ST-T wave changes but no Q waves on the ECG, also failed to produce other evidence of tissue necrosis or elevation of enzyme concentrations in plasma. The enzymes they studied (SGOT and LDH), however, were not specific for myocardial necrosis. In the mid-1960s Hess21 and others22-24 reported the use of total CPK in the clinical diagnosis of myocardial infarction. This enzyme was reported to have some advantage over SGOT and LDH because its relative increase in Table 2 Parameter Sensitivity and Specificity* plasma was greater and earlier following the myocardial necrosis. Sobel and his co-workers25 investigated the kinetics of both the appearance and subsequent clearance of total CPK activity from plasma following myocardial infaretion in experimental animals. A knowledge of these kinetics potentially has led to a noninvasive technic for estimating the size of a myocardial infarction. It should be noted, however, that the high incidence of falsely elevated total CPK reported by others and confirmed in this report, imposes serious limitations on the use of the total CPK as a diagnostic aid. It also seems very probable that, in man, extrapolations of infarct size from measurements of total CPK will be subject to numerous errors and possible misinterpretations. Earlier, Karliner and Sobel26 had investigated the use of glyceraldehyde phosphate dehydrogenase because of its rapid and transient appearance in plasma after acute infarction on experimental animals. This enzyme offered a capability for detection of extensions of myocardial necrosis but was also found, like total CPK, to lack specificity. The MB isoenzyme of CPK would seem to offer a reasonable solution to these problems. It is both a sensitive and specific indicator of myocardial necrosis. Its appearance and disappearance are rapid enough that it should be a sensitive index of subsequent extensions of infarction. The concepts developed by Sobel and his colleagues for extrapolating infarct size from total CPK should be applied to the analysis of the MB fraction of CPK, and the results of such an analysis might provide an accurate technic for estimating the size of myocardial infarction.
The usefulness of serial changes of the total CPK in the diagnosis of acute myocardial infarction would appear from previous results and our own to have two significant limitations.27 First, CPK is present in abundant quantity in both heart and skeletal muscle leading to a high incidence of falsely elevated total CPK. This problem could be solved almost totally by the identification of the isoenzymes of CPK. A second limitation to the use of CPK in the diagnosis of infarction is due to persistence of the elevation for only 2-3 days after the onset of infarction. This problem is accentuated with determination of the isoenzymes of CPK, since the MB form disappears approximately 24 hours before total CPK returns to normal. Thus, while the isoenzymes of CPK are both specific and sensitive for myocardial injury, their diagnostic value will be applicable only to those patients who are seen early after the onset of symptoms. It is of interest to note that reversal of the normal LDH,1: LDH2 ratio is both relatively sensitive and specific for myocardial infarction. The finding of an abnormal LDH1: LDH2 ratio adds certainty to the diagnosis of infarction, and this abnormal ratio persists for several days, thus making it more useful in the patient who is seen more than 24-48 hours after the onset of symptoms.
The technic described in this report provides a reproducible, relatively uncomplicated, and inexpensive approach to the diagnosis of myocardial necrosis in patients who present symptoms that suggest acute myocardial infarction. The results of our analysis indicate that the determination of the CPK-MB fraction in plasma provides both a sensitive and specific indicator of myocardial uiecrosis. Its early appearance in plasma after the onset of symptoms in patients who have suffered myocardial infarction makes an early diagnosis possible. The rapid return of CPK-MB levels to the normal range makes this enzyme particularly useful in the recognition of extensions of infarction which occur subsequent to the initial episode. The ability to quantitate the CPK-MB fraction, its sensitivity and specificity, and its rapid appearance and disappearance make this enzyme ideal for testing feasibility of quantitating infarct size and for evaluating therapeutic interventions which are aimed at protection of the ischemic myocardium.
